Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy

類似資料

• Erratum: Correction of Notes. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
  著者:: Suh, Young Sun, 等
  出版事項: (2014)
• Anti-TNF-α Therapy for Ankylosing Spondylitis
  著者:: Son, Jung-Hwan, 等
  出版事項: (2010)
• Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
  著者:: Jiwon Yang, 等
  出版事項: (2025-07-01)
• Recommendations for starting anti TNF-α in patients with ankylosing spondylitis
  著者:: L. Olivieri, 等
  出版事項: (2003-12-01)
• Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
  著者:: Kang, Ji-Hyoun, 等
  出版事項: (2014)